Crossmark

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

Crossref DOI link: https://doi.org/10.1038/s41598-022-18118-7

Published Online: 2022-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Denisova, Oxana V.

Merisaari, Joni

Kaur, Amanpreet

Yetukuri, Laxman

Jumppanen, Mikael

von Schantz-Fant, Carina

Ohlmeyer, Michael

Wennerberg, Krister

Aittokallio, Tero

Taipale, Mikko

Westermarck, Jukka
Funding

Funding for this research was provided by:

Suomen Kulttuurirahasto (00160159)

Turku Doctoral Programme of Molecular Medicine

Academy of Finland

Jane and Aatos Erkko Foundation
License Information

Text and Data Mining valid from 2022-08-13

Version of Record valid from 2022-08-13
More Information

Article History

Received: 24 May 2022

Accepted: 5 August 2022

First Online: 13 August 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below